BioTek's new Synergy^TM H4 Hybrid Microplate Reader has received Transcreener® approval from BellBrook Labs (Madison, WI). The approval extends to the Transcreener Fluorescence Polarization, Far Red, Red Fluorescence (FI) and Red TR-FRET assays, and means that the Synergy H4 meets strict standards in instrument setup and assay performance. 

Synergy H4 is a new class of multi-mode microplate readers that uses patent pending Hybrid Technology^TM to combine sensitive filter-based optics and flexible monochromator-based optics in one compact instrument for endless flexibility in current and future microplate-based assay choice. Additionally, Synergy H4 is compatible with BioTek's Take3^TM Multi-Volume Plate for low-volume direct measurements without dilution down to 2 μL.

BioTek Instruments, Inc., headquartered in Winooski, VT, USA, is a worldwide leader in the design, manufacture, and sale of microplate instrumentation and software. BioTek instrumentation is used to aid in the advancement of life science research, facilitate the drug discovery process and to enable cost-effective quantification of disease relevant molecules in the clinic.